Vanguard Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $125M | Sell |
4,812,955
-384,612
| -7% | -$9.15M | ﹤0.01% | 1775 |
|
|
2025
Q3 | $134M | Sell |
5,197,567
-208,397
| -4% | -$5.12M | ﹤0.01% | 1728 |
|
|
2025
Q2 | $129M | Buy |
5,405,964
+164,160
| +3% | +$4.14M | ﹤0.01% | 1721 |
|
|
2025
Q1 | $130M | Sell |
5,241,804
-22,115
| -0.4% | -$529K | ﹤0.01% | 1678 |
|
|
2024
Q4 | $99.2M | Sell |
5,263,919
-34,764
| -0.7% | -$610K | ﹤0.01% | 1872 |
|
|
2024
Q3 | $79.7M | Buy |
5,298,683
+213,852
| +4% | +$3.66M | ﹤0.01% | 1983 |
|
|
2024
Q2 | $145M | Sell |
5,084,831
-28,553
| -0.6% | -$813K | ﹤0.01% | 1663 |
|
|
2024
Q1 | $149M | Buy |
5,113,384
+14,960
| +0.3% | +$460K | ﹤0.01% | 1669 |
|
|
2023
Q4 | $172M | Buy |
5,098,424
+141,719
| +3% | +$4.15M | ﹤0.01% | 1592 |
|
|
2023
Q3 | $152M | Buy |
4,956,705
+4,393
| +0.1% | +$158K | ﹤0.01% | 1575 |
|
|
2023
Q2 | $198M | Sell |
4,952,312
-25,906
| -0.5% | -$1.07M | ﹤0.01% | 1479 |
|
|
2023
Q1 | $203M | Buy |
4,978,218
+53,023
| +1% | +$2.11M | 0.01% | 1449 |
|
|
2022
Q4 | $190M | Buy |
4,925,195
+56,750
| +1% | +$2.76M | 0.01% | 1465 |
|
|
2022
Q3 | $259M | Buy |
4,868,445
+55,188
| +1% | +$3.07M | 0.01% | 1232 |
|
|
2022
Q2 | $281M | Buy |
4,813,257
+125,138
| +3% | +$8.2M | 0.01% | 1219 |
|
|
2022
Q1 | $358M | Buy |
4,688,119
+22,164
| +0.5% | +$1.48M | 0.01% | 1180 |
|
|
2021
Q4 | $281M | Sell |
4,665,955
-102,108
| -2% | -$5.63M | 0.01% | 1396 |
|
|
2021
Q3 | $267M | Buy |
4,768,063
+43,134
| +0.9% | +$2.49M | 0.01% | 1414 |
|
|
2021
Q2 | $287M | Buy |
4,724,929
+218,398
| +5% | +$13.8M | 0.01% | 1396 |
|
|
2021
Q1 | $316M | Buy |
4,506,531
+139,265
| +3% | +$9.95M | 0.01% | 1274 |
|
|
2020
Q4 | $261M | Buy |
4,367,266
+78,823
| +2% | +$4.62M | 0.01% | 1304 |
|
|
2020
Q3 | $258M | Sell |
4,288,443
-87,536
| -2% | -$5.09M | 0.01% | 1108 |
|
|
2020
Q2 | $230M | Buy |
4,375,979
+9,160
| +0.2% | +$383K | 0.01% | 1188 |
|
|
2020
Q1 | $146M | Buy |
4,366,819
+22,265
| +0.5% | +$925K | 0.01% | 1316 |
|
|
2019
Q4 | $197M | Sell |
4,344,554
-87,274
| -2% | -$3.71M | 0.01% | 1397 |
|
|
2019
Q3 | $169M | Buy |
4,431,828
+502,417
| +13% | +$20.1M | 0.01% | 1436 |
|
|
2019
Q2 | $171M | Buy |
3,929,411
+7,946
| +0.2% | +$337K | 0.01% | 1456 |
|
|
2019
Q1 | $149M | Buy |
3,921,465
+136,320
| +4% | +$5.32M | 0.01% | 1524 |
|
|
2018
Q4 | $163M | Buy |
3,785,145
+143,728
| +4% | +$6.71M | 0.01% | 1377 |
|
|
2018
Q3 | $179M | Buy |
3,641,417
+243,213
| +7% | +$10.5M | 0.01% | 1467 |
|
|
2018
Q2 | $109M | Buy |
3,398,204
+114,756
| +3% | +$3.96M | ﹤0.01% | 1733 |
|
|
2018
Q1 | $102M | Buy |
3,283,448
+29,947
| +0.9% | +$1.07M | ﹤0.01% | 1700 |
|
|
2017
Q4 | $149M | Buy |
3,253,501
+85,584
| +3% | +$3.39M | 0.01% | 1485 |
|
|
2017
Q3 | $119M | Buy |
3,167,917
+95,843
| +3% | +$3.86M | 0.01% | 1609 |
|
|
2017
Q2 | $147M | Buy |
3,072,074
+211,982
| +7% | +$9.84M | 0.01% | 1443 |
|
|
2017
Q1 | $130M | Buy |
2,860,092
+112,853
| +4% | +$4.88M | 0.01% | 1504 |
|
|
2016
Q4 | $88.7M | Buy |
2,747,239
+80,028
| +3% | +$2.67M | ﹤0.01% | 1700 |
|
|
2016
Q3 | $91.3M | Buy |
2,667,211
+79,990
| +3% | +$3.13M | 0.01% | 1616 |
|
|
2016
Q2 | $87.3M | Buy |
2,587,221
+64,898
| +3% | +$3.19M | 0.01% | 1605 |
|
|
2016
Q1 | $134M | Buy |
2,522,323
+53,485
| +2% | +$3.13M | 0.01% | 1276 |
|
|
2015
Q4 | $190M | Buy |
2,468,838
+73,068
| +3% | +$4.14M | 0.01% | 1045 |
|
|
2015
Q3 | $98.5M | Buy |
2,395,770
+73,175
| +3% | +$4.48M | 0.01% | 1440 |
|
|
2015
Q2 | $164M | Buy |
2,322,595
+82,059
| +4% | +$6.46M | 0.01% | 1193 |
|
|
2015
Q1 | $199M | Buy |
2,240,536
+114,403
| +5% | +$11.6M | 0.01% | 1047 |
|
|
2014
Q4 | $189M | Buy |
2,126,133
+31,205
| +1% | +$2.95M | 0.01% | 1013 |
|
|
2014
Q3 | $203M | Buy |
2,094,928
+14,813
| +0.7% | +$1.44M | 0.02% | 917 |
|
|
2014
Q2 | $191M | Buy |
2,080,115
+123,838
| +6% | +$9.43M | 0.02% | 988 |
|
|
2014
Q1 | $137M | Buy |
1,956,277
+155,459
| +9% | +$10.6M | 0.01% | 1156 |
|
|
2013
Q4 | $104M | Buy |
1,800,818
+503,302
| +39% | +$26.5M | 0.01% | 1294 |
|
|
2013
Q3 | $62.4M | Buy |
1,297,516
+530,896
| +69% | +$19.3M | 0.01% | 1568 |
|
|
2013
Q2 | $22.2M | Buy |
+766,620
| New | +$22.2M | ﹤0.01% | 2040 |
|
Other funds holding PCRX
DPCM
